HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma

Cellular Physiology and Biochemistry

Volumn 37, Issue 2, 2015, Pages 687-696

  Li, Jun ^a,b   Wang, Xiaochen ^a   Tang, Junwei ^a   Jiang, Runqiu ^a   Zhang, Wenjie ^a   Ji, Jie ^a   Sun, Beicheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED JIANGNING HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Hepatocellular carcinoma; HULC; Linc00152; Long non coding RNAs

Indexed keywords

BIOLOGICAL MARKER; HULC PROTEIN; LINC00152 PROTEIN; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG; HULC LONG NON-CODING RNA, HUMAN; LONG NON-CODING RNA LINC00152, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; METASTASIS; ONTOGENY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION PROCESS; AREA UNDER THE CURVE; BLOOD; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; MIDDLE AGED;

AREA UNDER CURVE; BIOMARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, LONG NONCODING; ROC CURVE; UP-REGULATION;

EID: 84941554263     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430387     Document Type: Article

References (28)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Tian H, Huang P, Zhao Z, Tang W, Xia J: HIF-1alpha plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression. Cell Physiol Biochem 2014;34:1536-1546.
3. Jiang HL, Xu D, Yu H, Ma X, Lin GF, Ma DY, Jin JZ: DAX-1 inhibits hepatocellular carcinoma proliferation by inhibiting beta-catenin transcriptional activity. Cell Physiol Biochem 2014;34:734-742.
4. Lafaro KJ, Demirjian AN, Pawlik TM: Epidemiology of Hepatocellular Carcinoma. Surg Oncol Clin N Am 2015;24:1-17.
5. Zhang YS, Chu JH, Cui SX, Song ZY, Qu XJ: Des-gamma-carboxy prothrombin (DCP) as a potential autologous growth factor for the development of hepatocellular carcinoma. Cell Physiol Biochem 2014;34:903-915.
6. Plentz RR, Boozari B, Malek NP: [Guideline compliant diagnostics of hepatocellular carcinoma]. Radiologe 2014;54:660-663.
7. Zhou L, Liu J, Luo F: Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006;12:1175-1181.
8. Schwarzenbach H, Hoon DS, Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11:426-437.
9. Zhou J, Lu S, Yang S, Chen H, Shi H, Miao M, Jiao B: MicroRNA-127 post-transcriptionally downregulates Sept7 and suppresses cell growth in hepatocellular carcinoma cells. Cell Physiol Biochem 2014;33:1537-1546.
10. Sanchez Y, Huarte M: Long non-coding RNAs: challenges for diagnosis and therapies. Nucleic Acid Ther 2013;23:15-20.
11. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F, Thum T: Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res 2014;114:1569-1575.
12. Lorenzen JM, Schauerte C, Kielstein JT, Hubner A, Martino F, Fiedler J, Gupta SK, Faulhaber-Walter R, Kumarswamy R, Hafer C, Haller H, Fliser D, Thum T: Circulating Long Noncoding RNA TapSAKI Is a Predictor of Mortality in Critically Ill Patients with Acute Kidney Injury. Clin Chem 2015;61:191-201
13. Zheng HT, Shi DB, Wang YW, Li XX, Xu Y, Tripathi P, Gu WL, Cai GX, Cai SJ: High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol 2014;7:3174-3181.
14. Wang F, Ren S, Chen R, Lu J, Shi X, Zhu Y, Zhang W, Jing T, Zhang C, Shen J, Xu C, Wang H, Wang H, Wang Y, Liu B, Li Y, Fang Z, Guo F, Qiao M, Wu C, Wei Q, Xu D, Shen D, Lu X, Gao X, Hou J, Sun Y: Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer. Oncotarget 2014;5:11091-11102.
15. Zhang Z, Hao H, Zhang CJ, Yang XY, He Q, Lin J: [Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer]. Zhonghua Yi Xue Za Zhi 2012;92:384-387.
16. Srivastava AK, Singh PK, Rath SK, Dalela D, Goel MM, Bhatt ML: Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder. Tumour Biol 2014;35:11435-11442.
17. Han Y, Liu Y, Gui Y, Cai Z: Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol 2013;107:555-559.
18. Nissan A, Stojadinovic A, Mitrani-Rosenbaum S, Halle D, Grinbaum R, Roistacher M, Bochem A, Dayanc BE, Ritter G, Gomceli I, Bostanci EB, Akoglu M, Chen YT, Old LJ, Gure AO: Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues. Int J Cancer 2012;130:1598-1606.
19. Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, Xiao B, Guo J: Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol 2014;35:5441-5447.
20. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, Cheunsuchon P, Louis DN, Klibanski A: Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 2010;70:2350-2358.
21. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder R, Trauner M, Zatloukal K: Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007;132:330-342.
22. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM, Zheng SS: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012;29:1810-1816.
23. Tu ZQ, Li RJ, Mei JZ, Li XH: Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol 2014;7:4303-4309.
24. Zhao J, Greene CM, Gray SG, Lawless MW: Long noncoding RNAs in liver cancer: what we know in 2014. Expert Opin Ther Targets 2014;18:1207-1218.
25. Seo SI, Kim SS, Choi BY, Lee SH, Kim SJ, Park HW, Kim HS, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK: Clinical significance of elevated serum alpha-fetoprotein (AFP) level in acute viral hepatitis A (AHA). Hepatogastroenterology 2013;60:1592-1596.
26. Wong CR, Garcia RT, Trinh HN, Lam KD, Ha NB, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH: Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci 2009;54:2712-2721.
27. Li H, Li Y, Liu D, Sun H, Liu J: miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells. Cell Physiol Biochem 2013;32:448-458.
28. Yang G, Lu X, Yuan L: LncRNA: a link between RNA and cancer. Biochim Biophys Acta 2014;1839:1097-1109.